In vitro characterization of S-23 metabolites produced by human liver microsomes, and subsequent application to urine after a controlled oral administration
Authors:
- 15 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 212, 114660
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Identification of S22 (ostarine) in human nails and hair using LC‐HRMS. Application to two authentic casesDrug Testing and Analysis, 2020
- Investigation of the metabolism of the selective androgen receptor modulator LGD‐4033 in equine urine, plasma and hair following oral administrationDrug Testing and Analysis, 2019
- Human in vivo metabolism study of LGD‐4033Drug Testing and Analysis, 2018
- Detection of LGD‐4033 and its metabolites in athlete urine samplesDrug Testing and Analysis, 2016
- In vitro metabolism study of a black market product containing SARM LGD‐4033Drug Testing and Analysis, 2016
- Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancerCurrent Opinion in Supportive & Palliative Care, 2013
- Selective androgen receptor modulators:in vitroandin vivometabolism and analysisFood Additives & Contaminants: Part A, 2013
- Characterization of in vitro generated metabolites of the selective androgen receptor modulators S‐22 and S‐23 and in vivo comparison to post‐administration canine urine specimensDrug Testing and Analysis, 2010
- Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator andarine (S‐4) for routine doping control purposesRapid Communications in Mass Spectrometry, 2010
- Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic BenefitJournal of Medicinal Chemistry, 2009